Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
. 2018;1804:401-410.
doi: 10.1007/978-1-4939-8552-4_19.

Pharmacological Modulation of Glycosphingolipid Metabolism

Affiliations

Pharmacological Modulation of Glycosphingolipid Metabolism

Jin-Ichi Inokuchi et al. Methods Mol Biol. .

Abstract

The experimental approach to deplete cellular glycosphingolipids (GSLs) with the specific inhibitors of glycosphingolipid biosynthesis has the potential to identify functions of endogenous GSLs. Most GSLs are derived from glucosylceramide (GlcCer). D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) inhibits GIcCer synthase and has been used extensively to study the biological functions of living cells. D-PDMP inhibits mTORC1 activity, which is independent of its inhibitory activity on GlcCer synthase. We also developed an analog of D-PDMP, D-threo-1-phenyl-2-benzyloxycarbonylamino-3-pyrrolidino-1-propanol (D-PBPP) lacking the effect on mTORC1. Here, we summarize the effects of D-PDMP and D-PBPP on the metabolism of GSLs and cell growth.

Keywords: D-PBPP; D-PDMP; Gangliosides; Glucosylceramide (GlcCer) synthase; Glycolsphingolipids; mTORC1.

Similar articles

See all similar articles

MeSH terms

LinkOut - more resources

Feedback